Doctor Tatyana Kuropatkina

Tatyana was born and lived until school graduation in the city of Ust-Kamenogorsk, East Kazakhstan. In 2017 she graduated from the Siberian state university with a degree in pharmacy and received the qualification of a pharmacist. In 2020 she graduated from postgraduate studies in pharmacology at the Faculty of Fundamental Medicine at Lomonosov Moscow State University. During her postgraduate studies she worked on studying the effect of a new solubilized form of ubiquinol and its combination with selenium in a monocrotaline-induced model of pulmonary hypertension in male and female Wistar rats.